Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 3,578 shares at $80.05 ($286K) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $286k KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.04 | 823 | $66K | 23.0% |
| 2 | $80.04 | 823 | $66K | 23.0% |
| 3 | $80.05 | 966 | $77K | 27.0% |
| 4 | $80.05 | 966 | $77K | 27.0% |
| Total | $80.05 avg | 3,578 | $286K | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |